Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease
Clinical trial NCT05593575 · COMPLETED
Trial details
- NCT number
- NCT05593575
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-22
- Primary completion
- 2024-12-31
- Enrollment
- 305
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.